Analytical Science

Frank Fischer and Sven Poetzsch have a shared goal at Merck: to understand how medicines interact with human biology.

The development of an industrial process should begin right at the start – the preclinical stage.

A new center for electron bio-imaging was officially opened by one of the three Nobel Prize winners.

Sitting Down With... Melissa Hanna-Brown, Analytical Technology & Innovation Lead, Pfizer Global R&D, Sandwich, UK.

Where would drug development be without liquid chromatography-mass spectrometry – the hyphenated technique more commonly known as LC-MS?

A robotic arm takes mass spec analysis of 3D objects to the next level.

Making cancer drugs cheaper and more effective – with a paper “coffee” filter.

mAbs are an important growth area for the biopharma industry – so we need more effective purification technologies.

Streamlined workflows help scientists plot a course for painless peptide mapping

The path to market for a biosimilar involves an abbreviated approval process, focused on proving “biosimilarity”.